Reply to the Letter to the Editor: "Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine" by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?
- PMID: 35436727
- PMCID: PMC9010772
- DOI: 10.1016/j.ebiom.2022.104005
Reply to the Letter to the Editor: "Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine" by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?
Conflict of interest statement
Declaration of interests The authors declare no conflict of interest.
Comment on
-
Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine.EBioMedicine. 2022 May;79:104006. doi: 10.1016/j.ebiom.2022.104006. Epub 2022 Apr 14. EBioMedicine. 2022. PMID: 35430452 Free PMC article. No abstract available.
References
-
- European Centre for Disease Prevention and Control . ECDC; Stockholm: 2021. Considerations for the use of saliva as sample material for COVID-19 testing. 3 May 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical